SNOA Sonoma Pharmaceuticals, Inc.

Fundamentals / CIK 0001367083 / USD

Sonoma Pharmaceuticals, Inc. reported $23.49M in revenue and a net loss of $1.80M for the trailing twelve months ended September 30, 2026 (up 28.0% year over year), with a 39.2% gross margin and a -3.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SNOA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$20.76M$10.38M$0-$15.06MFY 2017 Revenue: $12.82MFY 2017 Net Income: $9.27M2017FY 2018 Revenue: $16.66MFY 2018 Net Income: -$14.33M2018FY 2019 Revenue: $18.97MFY 2019 Net Income: -$11.80M2019FY 2020 Revenue: $17.93MFY 2020 Net Income: -$3.31M2020FY 2021 Revenue: $18.63MFY 2021 Net Income: -$3.95M2021FY 2022 Revenue: $12.63MFY 2022 Net Income: -$5.09M2022FY 2023 Revenue: $13.27MFY 2023 Net Income: -$5.15M2023FY 2024 Revenue: $12.73MFY 2024 Net Income: -$4.83M2024FY 2025 Revenue: $14.29MFY 2025 Net Income: -$3.46M2025FY 2026 Revenue: $19.53MFY 2026 Net Income: -$3.17M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Revenue $19.53M $14.29M $12.73M $13.27M $12.63M $18.63M $17.93M $18.97M $16.66M $12.82M
Cost of Revenue $12.11M $8.82M $7.99M $8.79M $8.63M $12.07M $9.81M $10.09M $9.35M $7.16M
Gross Profit $7.42M $5.46M $4.75M $4.48M $3.99M $6.56M $8.12M $8.88M $7.31M $5.67M
Research & Development $2.27M $1.81M $1.87M $207K $125K $555K $1.34M $1.52M $1.57M $1.58M
Selling, General & Admin $7.61M $7.36M $7.58M $8.84M $9.76M $9.45M $14.17M $18.62M $19.92M $17.07M
Total Operating Expenses $9.88M $9.18M $9.45M $9.05M $9.88M $10.01M $15.51M $20.14M $21.50M $18.64M
Operating Income -$2.46M -$3.71M -$4.70M -$4.57M -$5.89M -$3.45M -$7.39M -$11.26M -$14.19M -$12.97M
EBITDA -$2.32M -$3.57M -$4.53M -$4.45M -$5.70M -$3.22M -$7.08M -$10.80M -$13.70M -$12.73M
Interest Income -- -- -- -- -- $16K $50K $190K $258K $22K
Interest Expense -- -- -- -- -- $12K $16K $33K $40K $3.0K
Income Before Tax -$3.42M -$2.91M -$5.03M -$5.18M -$5.42M -$3.90M -$3.54M -$11.34M -$14.28M -$12.94M
Income Tax Expense -$244K $550K -$196K -$33K -$332K $713K $29K $458K $50K -$4.27M
Net Income -$3.17M -$3.46M -$4.83M -$5.15M -$5.09M -$3.95M -$3.31M -$11.80M -$14.33M $9.27M
Basic EPS -$1.89 -$2.79 -$10.63 -$30.40 -$38.40 -$39.40 -$44.80 -$2,298.83 -$5,128.71 $396.04
Diluted EPS -$1.89 -$2.79 -$10.63 -$30.40 -$38.40 -$39.40 -$44.80 -$2,298.83 -$5,128.71 $396.04
Basic Shares Outstanding 1.7M 1.2M 455.0K 169.7K 133 99.8K 73.8K 5.1K 2.8K 23.5K
Diluted Shares Outstanding 1.7M 1.2M 455.0K 169.7K 133 99.8K 73.8K 5.1K 2.8K 23.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $7.17M $6.41M $5.56M $4.35M $5.60M $4.01M $3.75M $3.56M
Cost of Revenue $4.37M $3.83M $3.38M $2.70M $3.48M $2.55M $2.23M $2.29M
Gross Profit $2.81M $2.58M $2.18M $1.65M $2.12M $1.46M $1.53M $1.27M
Research & Development $469K $597K $545K $557K $575K $594K $411K $427K
Selling, General & Admin $2.05M $2.02M $1.99M $1.77M $1.88M $1.97M $1.77M $1.87M
Total Operating Expenses $2.52M $2.62M $2.53M $2.33M $2.46M $2.56M $2.18M $2.30M
Operating Income $290K -$40K -$351K -$678K -$337K -$1.09M -$656K -$1.03M
EBITDA -- -$8.0K -- -$644K -$301K -$1.06M -- -$998K
Income Before Tax $382K -$330K -$497K -$949K -$731K -$1.24M -$528K -$919K
Income Tax Expense $448K $0 $84K -$130K -$197K -$1.0K $248K $9.0K
Net Income -$66K -$330K -$581K -$819K -$534K -$1.24M -$776K -$928K
Basic EPS -$0.01 -$0.09 -- -$0.48 -$0.32 -$0.76 -- -$0.63
Diluted EPS -$0.01 -$0.09 -- -$0.48 -$0.32 -$0.76 -- -$0.63
Basic Shares Outstanding 4.9M 3.8M -- 1.7M 1.6M 1.6M -- 1.5M
Diluted Shares Outstanding 4.9M 3.8M -- 1.7M 1.6M 1.6M -- 1.5M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Cash & Cash Equivalents $2.40M $5.37M $3.13M $3.82M $7.40M $4.22M $3.69M $3.69M $10.07M $17.46M
Cash & Short-Term Investments $2.40M $5.37M $3.13M $3.82M $7.40M $4.22M $3.69M $3.69M $10.07M $17.46M
Accounts Receivable, Net $2.53M $2.23M $2.90M $2.57M $2.41M $2.81M $3.97M $3.48M $1.54M $2.11M
Inventory $3.65M $2.92M $2.72M $2.86M $2.66M $2.53M $2.18M $3.41M $2.87M $2.22M
Total Current Assets $12.10M $12.65M $12.55M $13.80M $16.43M $12.98M $12.28M $12.50M $16.25M $22.64M
Property, Plant & Equipment, Net $310K $225K $365K $488K $320K $360K $365K $727K $1.14M $1.24M
Other Non-Current Assets $64K $74K $66K $73K $77K $112K $64K $122K $494K $80K
Total Non-Current Assets $1.86M $1.04M $2.19M $2.43M $2.42M $2.00M $2.28M $1.95M $2.95M $2.82M
Total Assets $13.96M $13.69M $14.74M $16.23M $18.84M $14.99M $14.56M $14.45M $19.21M $25.46M
Accounts Payable $1.92M $953K $607K $841K $1.64M $1.77M $2.07M $1.25M $1.27M $1.25M
Short-Term Debt $222K $220K $323K $431K -- $596K $481K $322K $230K $123K
Deferred Revenue (Current) $284K $641K $478K $160K $1.22M $267K $228K $47K $147K $345K
Other Current Liabilities -- -- -- -- -- -- $0 $270K $0 --
Total Current Liabilities $4.83M $4.10M $3.72M $3.72M $5.82M $4.08M $4.73M $3.59M $3.26M $3.29M
Long-Term Debt -- -- -- -- $0 $1.31M $0 $12K $32K $45K
Deferred Revenue (Non-Current) $0 $17K $87K $140K $182K $229K $245K $356K $443K $527K
Total Non-Current Liabilities $6.03M $5.19M $4.88M $4.54M $4.33M $5.55M $4.21M $368K $619K $740K
Total Liabilities $10.87M $9.28M $8.60M $8.25M $10.15M $9.62M $8.94M $3.96M $3.88M $4.03M
Total Debt (incl. Leases) $842K $305K $608K $849K $559K $2.67M $1.48M $1.67M $262K $168K
Common Stock $0 $0 $0 $5.0K $2.0K $2.0K $2.0K $2.0K $1.0K $1.0K
Retained Earnings -$201.0M -$197.8M -$194.3M -$189.5M -$184.4M -$179.3M -$175.3M -$169.2M -$157.4M -$143.1M
Accumulated Other Comp. Income -$3.24M -$4.38M -$2.72M -$3.42M -$4.31M -$4.58M -$5.61M -$4.35M -$3.98M -$4.18M
Total Stockholders' Equity $3.10M $4.41M $6.14M $7.98M $8.70M $5.36M $5.62M $7.77M $15.33M $21.43M
Total Equity $3.10M $4.41M $6.14M $7.98M $8.70M $5.36M $5.62M $7.77M $15.33M $21.43M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.61M $5.34M $2.40M $2.56M $3.04M $3.60M $5.37M $5.24M
Cash & Short-Term Investments $4.61M $5.34M $2.40M $2.56M $3.04M $3.60M $5.37M $5.24M
Accounts Receivable, Net $3.58M $3.18M $2.53M $2.38M $2.70M $2.60M $2.23M $2.40M
Inventory $3.51M $3.79M $3.65M $3.70M $3.63M $3.80M $2.92M $3.14M
Total Current Assets $15.34M $16.27M $12.10M $12.14M $12.50M $13.11M $12.65M $12.38M
Property, Plant & Equipment, Net $294K $290K $310K $314K $284K $301K $225K $215K
Other Non-Current Assets $64K $66K $64K $64K $84K $80K $74K $73K
Total Non-Current Assets $1.76M $1.84M $1.86M $1.48M $1.35M $1.49M $1.04M $1.29M
Total Assets $17.10M $18.11M $13.96M $13.62M $13.86M $14.59M $13.69M $13.67M
Accounts Payable $1.55M $2.19M $1.92M $1.65M $1.40M $2.05M $953K $1.40M
Short-Term Debt $57K $140K $222K $0 $56K $139K $220K $0
Deferred Revenue (Current) $45K $282K $284K $314K $750K $731K $641K $302K
Total Current Liabilities $4.42M $5.45M $4.83M $4.22M $4.32M $4.85M $4.10M $3.70M
Deferred Revenue (Non-Current) -- -- $0 $0 $0 $4.0K $17K $30K
Total Non-Current Liabilities $6.07M $6.07M $6.03M $5.97M $5.75M $5.69M $5.19M $5.09M
Total Liabilities $10.49M $11.51M $10.87M $10.19M $10.07M $10.54M $9.28M $8.80M
Total Debt (incl. Leases) $602K $739K $842K $655K $535K $675K $305K $119K
Common Stock $0 $0 $0 $0 $0 $0 $0 $0
Retained Earnings -$201.4M -$201.3M -$201.0M -$200.4M -$199.6M -$199.0M -$197.8M -$197.0M
Accumulated Other Comp. Income -$3.33M -$3.01M -$3.24M -$3.19M -$3.37M -$3.57M -$4.38M -$4.55M
Total Stockholders' Equity $6.61M $6.59M $3.10M $3.43M $3.79M $4.06M $4.41M $4.87M
Total Equity $6.61M $6.59M $3.10M $3.43M $3.79M $4.06M $4.41M $4.87M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Net Income -$3.17M -$2.91M -$4.92M -$5.18M -$5.40M -$3.52M -$3.31M -$11.80M -$14.33M $9.27M
Depreciation & Amortization $139K $138K $176K $125K $186K $227K $312K $453K $490K $248K
Stock-Based Compensation $255K $224K $516K $669K $382K $371K $839K $1.64M $2.50M $2.15M
Change in Receivables -$122K $434K -$230K -$4.0K $1.97M $2.61M -$2.19M -$1.16M $11K -$2.0K
Change in Inventory -$465K -$388K $184K $0 -$100K -$65K $323K -$779K -$583K -$675K
Change in Payables -- -- -- -- -- -- $336K $5.0K $9.0K -$58K
Operating Cash Flow -$3.93M -$88K -$2.40M -$6.15M -$4.25M -$3.38M -$4.59M -$11.72M -$12.44M -$8.17M
Capital Expenditure -$192K -$80K -$2.0K -$269K -$137K -$179K -$206K -$100K -$187K -$394K
Free Cash Flow -$4.12M -$168K -$2.40M -$6.42M -$4.38M -$3.56M -$4.80M -$11.82M -$12.63M -$8.56M
Sales & Maturities of Investments -- -- -- -- -- -- -- -- -- $0
Investing Cash Flow -$192K -$80K -$2.0K -$258K -$99K $388K $3.64M -$131K -$201K $18.22M
Common Stock Issued $427K $3.08M $1.78M $2.87M $7.55M $0 $1.38M $957K $968K $0
Financing Cash Flow $477K $3.03M $1.68M $2.49M $7.40M $3.31M $1.03M $5.49M $5.24M -$32K
Net Change in Cash -$2.98M $2.25M -$692K -$3.58M $3.18M $529K $2.0K -$6.38M -$7.39M $9.99M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$66K -$330K -$581K -$819K -$534K -$1.24M -$776K -$928K
Depreciation & Amortization -- $32K -- $34K $36K $36K -- $33K
Stock-Based Compensation $95K $58K $135K $24K $39K $57K $90K $13K
Change in Receivables -$422K -$650K -$168K $340K -$78K -$216K $215K $646K
Change in Inventory $200K -$81K $19K -$40K $208K -$652K $291K -$309K
Operating Cash Flow -$736K -$649K -$519K -$764K -$635K -$2.02M -$95K $565K
Capital Expenditure -$42K -$2.0K -$29K -$47K -$10K -$106K -$47K -$2.0K
Free Cash Flow -$778K -$651K -$548K -$811K -$645K -$2.12M -$142K $563K
Investing Cash Flow -$42K -$2.0K -$29K -$47K -$10K -$106K -$47K -$2.0K
Common Stock Issued $312K $3.54M $161K $266K $0 $0 $0 $790K
Financing Cash Flow $232K $3.45M $387K $210K -$62K -$58K $242K $708K
Net Change in Cash -$729K $2.94M -$162K -$474K -$570K -$1.77M $138K $1.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31 Mar 31
Gross Margin 38.0% 38.2% 37.3% 33.7% 31.6% 35.2% 45.3% 46.8% 43.9% 44.2%
Operating Margin -12.6% -26.0% -36.9% -34.4% -46.6% -18.5% -41.2% -59.3% -85.2% -101.2%
Net Profit Margin -16.3% -24.2% -38.0% -38.8% -40.3% -21.2% -18.5% -62.2% -86.0% 72.3%
Return on Equity (ROE) -102.6% -78.4% -78.8% -64.6% -58.5% -73.7% -58.8% -151.8% -93.5% 43.3%
Return on Assets (ROA) -22.7% -25.2% -32.8% -31.7% -27.0% -26.4% -22.7% -81.7% -74.6% 36.4%
Current Ratio 2.50x 3.09x 3.37x 3.71x 2.82x 3.18x 2.60x 3.48x 4.98x 6.89x
Quick Ratio 1.75x 2.38x 2.64x 2.94x 2.37x 2.56x 2.14x 2.53x 4.11x 6.21x
Debt to Equity 0.27x 0.07x 0.10x 0.11x 0.06x 0.50x 0.26x 0.21x 0.02x 0.01x
Revenue Growth (YoY) +36.7% +12.2% -4.0% +5.1% -32.2% +3.9% -5.5% +13.9% +29.9% +36.9%
Gross Profit Growth (YoY) +35.7% +15.2% +6.0% +12.1% -39.1% -19.2% -8.5% +21.5% +29.0% +114.0%
Net Income Growth (YoY) -- -- -- -- -- -- -- -- -254.5% --
EPS Growth (YoY) -- -- -- -- -- -- -- -- -1395.0% --
5Y Revenue / Share Growth -93.8% -95.3% -99.2% -98.7% +17271.1% -63.6% -81.2% +106.7% +113.3% -99.9%
10Y Revenue / Share Growth -97.7% -99.1% -98.4% -97.2% -77.6% +292.5% -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -9775.2% -- -- -570.5% -- --
10Y Net Income / Share Growth -- -- -102.2% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 39.2% 38.9% 38.0% 38.2% 37.7% 37.7% 38.2% 36.0%
Operating Margin -3.3% -6.4% -12.6% -15.6% -18.4% -24.4% -26.0% -31.9%
Net Profit Margin -7.6% -10.3% -16.3% -19.0% -20.5% -23.8% -24.2% -26.8%
Return on Equity (ROE) -27.2% -34.3% -102.6% -98.2% -91.9% -87.6% -78.4% -77.0%
Return on Assets (ROA) -10.5% -12.5% -22.7% -24.7% -25.1% -24.4% -25.2% -27.4%
Current Ratio 3.48x 2.99x 2.50x 2.88x 2.89x 2.70x 3.09x 3.34x
Quick Ratio 2.68x 2.29x 1.75x 2.00x 2.05x 1.92x 2.38x 2.49x
Debt to Equity 0.09x 0.11x 0.27x 0.19x 0.14x 0.17x 0.07x 0.02x
Revenue Growth (YoY) +28.0% +59.6% +48.1% +22.0% +56.6% +18.4% +9.2% +13.6%
Gross Profit Growth (YoY) +32.4% +76.0% +42.7% +29.9% +55.8% +12.1% +40.1% -13.0%
Operating Cash Flow Growth (YoY) -- -- -- -235.2% -279.4% -- -162.5% --
Free Cash Flow Growth (YoY) -- -- -- -244.0% -296.6% -- -183.5% --
Source: SEC EDGAR CompanyFacts (CIK 0001367083) · from September 30, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal